 |
Prostatitis is associated with Prostate Cancer. Prostatitis was
evident in more than 1100 consecutive patients with Prostate Cancer. (Dianon Labs) |
 |
An EPS (expressed prostatic secretion) of >10 WBCs/HPF denotes
prostate inflammation/infection associated with Prostatitis (Stamey TG, etal.) |
 |
All patients on PEENUTS noting an elevated EPS improved (n=20) |
 |
Range of EPS studied 18 WBCs - TNTC (too numerous to count) |
 |
All patients on PEENUTS improved the health of their prostate by
lowering the EPS, by an average of 66% |
 |
Range of ages of patients participating on PEENUTS: 25 years - 64
years |
 |
Time to improvement of EPS using PEENUTS: 1
month - 15 months |
 |
EPS normalized in 27% of patients on PEENUTS; i.e. complete prostate
health re-established |
 |
Most dramatic Improvement of EPS in patients on PEENUTS: TNTC WBCs/HPF
decreasing to 0-3 WBCs/HPF |
 |
PEENUTS is one of the few prostate nutritional products in the world
to demonstrate benefit versus Prostatitis |
 |
PEENUTS was patented March 6, 2001 versus Prostatitis |
| |
|